CN115060882A - 用非稀有细胞检测稀有细胞的方法 - Google Patents

用非稀有细胞检测稀有细胞的方法 Download PDF

Info

Publication number
CN115060882A
CN115060882A CN202210699103.6A CN202210699103A CN115060882A CN 115060882 A CN115060882 A CN 115060882A CN 202210699103 A CN202210699103 A CN 202210699103A CN 115060882 A CN115060882 A CN 115060882A
Authority
CN
China
Prior art keywords
ctcs
cells
rare
cell
rare cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210699103.6A
Other languages
English (en)
Chinese (zh)
Inventor
P·昆
A·考拉特卡
J·坤肯
D·马里努茨
X·杨
J·R·史图尔普纳格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Epic Sciences Inc
Original Assignee
Scripps Research Institute
Epic Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute, Epic Sciences Inc filed Critical Scripps Research Institute
Publication of CN115060882A publication Critical patent/CN115060882A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Image Processing (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202210699103.6A 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法 Pending CN115060882A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25378709P 2009-10-21 2009-10-21
US61/253,787 2009-10-21
CN2010800578539A CN102782498A (zh) 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法
PCT/US2010/053431 WO2011050103A1 (en) 2009-10-21 2010-10-20 Method of using non-rare cells to detect rare cells

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2010800578539A Division CN102782498A (zh) 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法

Publications (1)

Publication Number Publication Date
CN115060882A true CN115060882A (zh) 2022-09-16

Family

ID=43900673

Family Applications (3)

Application Number Title Priority Date Filing Date
CN202210699103.6A Pending CN115060882A (zh) 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法
CN2010800578539A Pending CN102782498A (zh) 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法
CN201710186990.6A Pending CN107422127A (zh) 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN2010800578539A Pending CN102782498A (zh) 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法
CN201710186990.6A Pending CN107422127A (zh) 2009-10-21 2010-10-20 用非稀有细胞检测稀有细胞的方法

Country Status (8)

Country Link
US (4) US20120276555A1 (enExample)
EP (3) EP3385716A3 (enExample)
JP (3) JP6352588B2 (enExample)
CN (3) CN115060882A (enExample)
AU (4) AU2010310688A1 (enExample)
CA (1) CA2778328C (enExample)
ES (2) ES2556639T3 (enExample)
WO (1) WO2011050103A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120276555A1 (en) 2009-10-21 2012-11-01 Peter Kuhn Method of Using Non-Rare Cells to Detect Rare Cells
US9448163B2 (en) * 2010-03-05 2016-09-20 Konica Minolta Holdings, Inc. Method for detecting rare cell on observation region
JP5916991B2 (ja) * 2010-11-09 2016-05-11 オリンパス株式会社 遺伝子異常細胞の解析方法
WO2013006828A1 (en) * 2011-07-07 2013-01-10 Scripps Health Method of analyzing cardiovascular disorders and uses thereof
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
WO2013109944A1 (en) * 2012-01-18 2013-07-25 The Trustees Of The University Of Pennsylvania Methods for assessing risk for cancer using biomarkers
US10254286B2 (en) 2012-01-24 2019-04-09 Pfizer Inc. Methods for detecting 5T4-positive circulating tumor cells and methods of diagnosis of 5T4-positive cancer in a mammalian subject
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
CN105190400A (zh) * 2013-03-11 2015-12-23 罗氏血液诊断公司 对血细胞进行成像
US10222304B2 (en) 2013-03-15 2019-03-05 Massachusetts Institute Of Technology Deposition and imaging of particles on planar substrates
US10225483B1 (en) * 2013-05-01 2019-03-05 Pierce Biotechnology, Inc. Method and system for projecting image with differing exposure times
US10115034B2 (en) * 2013-05-01 2018-10-30 Life Technologies Holdings Pte Limited Method and system for projecting image with differing exposure times
JP6453592B2 (ja) 2013-09-25 2019-01-16 アークレイ株式会社 血液検体の処理方法
CN106062561B (zh) 2013-09-30 2021-11-09 斯克利普斯研究院 为了监测前列腺癌患者中的肿瘤进化进行循环肿瘤细胞的基因型和表型分析
EP3060680B1 (en) 2013-10-21 2019-02-27 The General Hospital Corporation Methods relating to circulating tumor cell clusters and the treatment of cancer
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
EP3080245B1 (en) * 2013-12-09 2021-05-26 The Scripps Research Institute Methods for the detection and quantification of circulating endothelial cells
US10147180B2 (en) 2013-12-19 2018-12-04 Axon Dx, Llc Cell detection, capture and isolation methods and apparatus
EA201691496A1 (ru) * 2014-01-27 2016-12-30 Эпик Сайенсиз, Инк. Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток
US20160040245A1 (en) * 2014-01-27 2016-02-11 Epic Sciences, Inc. Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
US20160011198A1 (en) * 2014-01-27 2016-01-14 Epic Sciences, Inc. Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
ES2868077T3 (es) * 2014-01-30 2021-10-21 Epic Sciences Inc Diagnóstico mediante células tumorales circulantes para biomarcadores predictivos de la resistencia a las terapias selectivas del receptor de andrógenos (RA)
EA201691497A1 (ru) * 2014-01-31 2017-01-30 Эпик Сайенсиз, Инк. Способы детектирования и количественного определения имитаторов циркулирующих опухолевых клеток
EP3108246B1 (en) 2014-02-21 2019-10-09 Epic Sciences, Inc. Methods for analyzing rare circulating cells
EP3140656B1 (en) * 2014-05-09 2021-02-17 The Scripps Research Institute Compositions and methods for fluid biopsy of melanoma
US20170285035A1 (en) * 2014-09-25 2017-10-05 Epic Sciences, Inc. Circulating tumor cell diagnostics for identification of resistance to androgen receptor targeted therapies
CN107407626B (zh) * 2014-09-26 2020-10-30 加利福尼亚大学董事会 评估癌症的疾病状况的方法
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
JP6737185B2 (ja) * 2015-01-29 2020-08-05 コニカミノルタ株式会社 相互作用する分子を有する血中細胞の同時検出方法
ES3007999T3 (en) * 2015-04-21 2025-03-21 Genentech Inc Compositions and methods for prostate cancer analysis
EP3303363A4 (en) * 2015-05-29 2019-01-23 Epic Sciences, Inc. INTRAPATIENT GENOMHETEROGENICITY OF INDIVIDUAL CIRCULATIVE TUMOR CELLS (CTCS) RELATED TO PHENOTYPIC CTC HETEROGENICITY IN METASTASED, CASTING RESISTANT PROSTATE CANCER (MCRPC)
WO2017079212A1 (en) * 2015-11-04 2017-05-11 Axon Dx, Llc Cell detection, capture, analysis, aggregation, and output methods and apparatus
JP6936984B2 (ja) * 2016-01-19 2021-09-22 東ソー株式会社 希少細胞を用いて癌患者の予後を予測する方法
US9739783B1 (en) * 2016-03-15 2017-08-22 Anixa Diagnostics Corporation Convolutional neural networks for cancer diagnosis
US10360499B2 (en) 2017-02-28 2019-07-23 Anixa Diagnostics Corporation Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis
US9934364B1 (en) 2017-02-28 2018-04-03 Anixa Diagnostics Corporation Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis
US11164082B2 (en) 2017-02-28 2021-11-02 Anixa Diagnostics Corporation Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis
CN108646034B (zh) * 2018-07-03 2020-10-23 珠海圣美生物诊断技术有限公司 细胞群中的稀有细胞判读方法
CN111079579B (zh) * 2019-12-02 2023-07-25 英华达（上海）科技有限公司 细胞图像的识别方法、装置以及系统
KR20220010132A (ko) 2020-07-17 2022-01-25 주식회사 엘지에너지솔루션 고로딩 전극을 위한 집전체용 시트의 압연 방법 및 고로딩 전극
JP7644458B2 (ja) * 2020-07-30 2025-03-12 浜松ホトニクス株式会社 判別装置、判別方法、判別プログラム及び記録媒体
CN113567672A (zh) * 2021-07-26 2021-10-29 江南大学附属医院 一种检测腹水或腹腔灌洗液中癌细胞的试剂盒
WO2023107566A1 (en) * 2021-12-07 2023-06-15 Epic Sciences, Inc. Enhanced characterization of breast cancer
CN114910455B (zh) * 2022-05-06 2025-06-20 马海燕 一种稀有单细胞识别轮廓的可视化的方法

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
AU9233698A (en) 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US20010018058A1 (en) 1997-12-24 2001-08-30 Reed Steven G. Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
US8192994B2 (en) 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
WO1999041613A1 (en) 1998-02-12 1999-08-19 Immunivest Methods and reagents for the rapid and efficient isolation of circulating cancer cells
EP1078257A4 (en) 1998-05-09 2007-07-18 Iconisys Inc METHOD AND APPARATUS FOR COMPUTER-ASSISTED DIAGNOSIS OF RARE CELLS, INCLUDING FETAL CELLS
US6960449B2 (en) 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
US7546210B2 (en) * 2000-06-08 2009-06-09 The Regents Of The University Of California Visual-servoing optical microscopy
EP1287114B1 (en) * 2000-06-08 2016-08-10 The Regents of The University of California Visual-servoing optical microscopy
US7033832B2 (en) 2000-10-13 2006-04-25 University Of Medicine And Dentistry Of New Jersey Endothelial cell—cell cohesion
US20030152927A1 (en) 2000-10-25 2003-08-14 Jakobsen Mogens Havsteen Closed substrate platforms suitable for analysis of biomolecules
US6701197B2 (en) 2000-11-08 2004-03-02 Orbotech Ltd. System and method for side to side registration in a printed circuit imager
ATE439588T1 (de) 2001-05-04 2009-08-15 Biosite Inc Diagnostische marker für akute herzerkrankungen und verfahren des gebrauchs
US20080009019A1 (en) * 2001-06-13 2008-01-10 Smithkline Beecham Corporation High throughput method for screening candidate compounds for biological activity
US7863012B2 (en) 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
DE60227678D1 (de) * 2001-08-23 2008-08-28 Immunivest Corp Analyse zirkulierender tumorzellen, fragmente und trümmer
US7943093B2 (en) 2001-12-12 2011-05-17 Erie Scientific Company Cover slip
AU2003219759B2 (en) * 2002-02-14 2011-01-20 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
US7305112B2 (en) 2002-10-15 2007-12-04 The Scripps Research Institute Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media
US7113624B2 (en) 2002-10-15 2006-09-26 Palo Alto Research Center Incorporated Imaging apparatus and method employing a large linear aperture
US7282180B2 (en) * 2003-07-02 2007-10-16 Immunivest Corporation Devices and methods to image objects
US7372985B2 (en) * 2003-08-15 2008-05-13 Massachusetts Institute Of Technology Systems and methods for volumetric tissue scanning microscopy
US8603763B2 (en) * 2004-04-08 2013-12-10 Cornell Research Foundation, Inc. Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
WO2006041453A1 (en) 2004-09-30 2006-04-20 Immunivest Corporation Circulating tumor cells (ctc’s): apoptotic assessment in prostate cancer patients
CN101099104B (zh) * 2004-11-24 2010-10-27 巴特尔纪念研究所 用于细胞成像的光学系统
US7280261B2 (en) 2004-12-20 2007-10-09 Palo Alto Research Center Incorporated Method of scanning and light collection for a rare cell detector
US20090081688A1 (en) * 2005-06-20 2009-03-26 Advanced Cell Diagnostics Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
US20070009389A1 (en) 2005-07-08 2007-01-11 Antti Seppo Slide deposition chamber
US9134237B2 (en) 2005-09-20 2015-09-15 Janssen Diagnotics, LLC High sensitivity multiparameter method for rare event analysis in a biological sample
US20090317836A1 (en) * 2006-01-30 2009-12-24 The Scripps Research Institute Methods for Detection of Circulating Tumor Cells and Methods of Diagnosis of Cancer in Mammalian Subject
US8337755B2 (en) * 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
US20080076727A1 (en) 2006-03-29 2008-03-27 John Wayne Cancer Institute Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
US20090105963A1 (en) * 2006-05-13 2009-04-23 Jesper Laursen Methods for Flow Cytometry Analyses of Un-Lysed Cells from Biological Fluids
DK2027470T3 (da) * 2006-06-02 2013-02-04 Pfizer Prod Inc Analyse for cirkulerende tumorceller
US20080124721A1 (en) * 2006-06-14 2008-05-29 Martin Fuchs Analysis of rare cell-enriched samples
CA2657621A1 (en) * 2006-07-14 2008-01-17 Aviva Biosciences Corporation Methods and compositions for detecting rare cells from a biological sample
US20080113358A1 (en) * 2006-07-28 2008-05-15 Ravi Kapur Selection of cells using biomarkers
MX2009002397A (es) * 2006-09-05 2009-03-16 Veridex Llc Metodos para clasificar imagenes celulares.
US8244021B2 (en) 2006-12-20 2012-08-14 Ventana Medical Systems, Inc. Quantitative, multispectral image analysis of tissue specimens stained with quantum dots
CN101226118B (zh) 2007-01-19 2010-06-16 中国医学科学院肿瘤研究所 一种兼容免疫荧光分析的细胞化学染色方法及其用途
WO2008151278A1 (en) 2007-06-05 2008-12-11 Nanopoint, Inc. Cell tray systems and methods
US8889361B2 (en) 2007-09-19 2014-11-18 The Research Foundation For The State University Of New York Gene expression signatures in enriched tumor cell samples
WO2009051734A1 (en) * 2007-10-17 2009-04-23 The General Hospital Corporation Microchip-based devices for capturing circulating tumor cells and methods of their use
US8088715B2 (en) 2007-11-13 2012-01-03 Ikonisys, Inc. Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescence microscope
US20090258365A1 (en) 2008-03-25 2009-10-15 Terstappen Leon W M M METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
WO2010005991A2 (en) 2008-07-07 2010-01-14 The Board Of Regents Of The University Of Texas System Circulating tumor and tumor stem cell detection using genomic specific probes
US9779213B2 (en) 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US8324280B2 (en) 2008-08-07 2012-12-04 The University Of British Columbia Treatment of prostate cancer with DDC inhibitor
CA2736178A1 (en) 2008-09-05 2010-03-11 Peter Kuhn Methods for the detection of circulating tumor cells
US20120276555A1 (en) 2009-10-21 2012-11-01 Peter Kuhn Method of Using Non-Rare Cells to Detect Rare Cells
US20130209493A1 (en) 2010-01-27 2013-08-15 Mariano Garcia-Blanco Biomakers for circulating tumor cells
EP2545186A1 (en) 2010-03-08 2013-01-16 Regents Of The University Of Minnesota Androgen receptor isoforms and methods
TWI539158B (zh) 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
US20140031250A1 (en) 2010-10-07 2014-01-30 David Tsai Ting Biomarkers of Cancer
JP6054303B2 (ja) 2010-12-30 2016-12-27 ファウンデーション メディシン インコーポレイテッドＦｏｕｎｄａｔｉｏｎ Ｍｅｄｉｃｉｎｅ， Ｉｎｃ． 腫瘍試料の多重遺伝子分析の最適化
AU2012209329A1 (en) 2011-01-24 2013-09-12 Epic Sciences, Inc. Methods for obtaining single cells and applications of single cell omics
WO2013006828A1 (en) 2011-07-07 2013-01-10 Scripps Health Method of analyzing cardiovascular disorders and uses thereof
US20130078667A1 (en) 2011-09-22 2013-03-28 Oscar B. Goodman Methods for detecting and collecting circulating tumor cells
WO2013049926A1 (en) 2011-10-06 2013-04-11 UNIVERSITé LAVAL PROGNOSTIC MARKERS OF INHERITED VARIATIONS IN THE 17β-HYDROXYSTEROID DEHYDROGENASE (HSD17B) GENES FOR PROSTATE CANCER
CN104428677A (zh) 2011-12-09 2015-03-18 斯克利普斯研究所 用于识别循环肿瘤细胞的设备、系统和方法
US20130171642A1 (en) 2011-12-30 2013-07-04 Ventana Medical Systems, Inc. Automated analysis of circulating tumor cells
US10254286B2 (en) 2012-01-24 2019-04-09 Pfizer Inc. Methods for detecting 5T4-positive circulating tumor cells and methods of diagnosis of 5T4-positive cancer in a mammalian subject
EP2855663B1 (en) 2012-06-01 2018-06-27 Creatv Microtech, Inc. Capture, identification and use of a new biomarker of solid tumors in body fluids
WO2014008155A1 (en) 2012-07-02 2014-01-09 The General Hospital Corporation Diagnosis and monitoring treatment of prostate cancer
US20140024024A1 (en) 2012-07-17 2014-01-23 General Electric Company Methods of detecting dna, rna and protein in biological samples
US9671405B2 (en) 2012-09-19 2017-06-06 Cornell University Identifying taxane sensitivity in prostate cancer patients
CA2889765C (en) 2012-10-26 2021-06-22 Minna D. BALBAS Androgen receptor variants and methods for making and using
CN105102978B (zh) 2013-02-02 2018-11-02 杜克大学 分离循环肿瘤细胞的方法
SG10201701380TA (en) 2013-03-15 2017-04-27 Genentech Inc Biomarkers and methods of treating pd-1 and pd-l1 related conditions
CN106062561B (zh) 2013-09-30 2021-11-09 斯克利普斯研究院 为了监测前列腺癌患者中的肿瘤进化进行循环肿瘤细胞的基因型和表型分析
WO2015073896A2 (en) 2013-11-15 2015-05-21 Psma Development Company, Llc Biomarkers for psma targeted therapy for prostate cancer
US20170192003A1 (en) 2013-12-03 2017-07-06 The Scripps Research Institute Compositions and methods for fluid biopsy of melanoma
EP3702785A1 (en) 2013-12-30 2020-09-02 The Scripps Research Institute Circulating tumor cell diagnostics for lung cancer
US20160011198A1 (en) 2014-01-27 2016-01-14 Epic Sciences, Inc. Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
EA201691496A1 (ru) 2014-01-27 2016-12-30 Эпик Сайенсиз, Инк. Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток
US20160040245A1 (en) 2014-01-27 2016-02-11 Epic Sciences, Inc. Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
ES2868077T3 (es) 2014-01-30 2021-10-21 Epic Sciences Inc Diagnóstico mediante células tumorales circulantes para biomarcadores predictivos de la resistencia a las terapias selectivas del receptor de andrógenos (RA)
EA201691497A1 (ru) 2014-01-31 2017-01-30 Эпик Сайенсиз, Инк. Способы детектирования и количественного определения имитаторов циркулирующих опухолевых клеток
EP3108246B1 (en) 2014-02-21 2019-10-09 Epic Sciences, Inc. Methods for analyzing rare circulating cells
US20170285035A1 (en) 2014-09-25 2017-10-05 Epic Sciences, Inc. Circulating tumor cell diagnostics for identification of resistance to androgen receptor targeted therapies
WO2016061064A1 (en) 2014-10-15 2016-04-21 Epic Sciences, Inc. Circulating tumor cell diagnostics for therapy targeting pd-l1
EP3303363A4 (en) 2015-05-29 2019-01-23 Epic Sciences, Inc. INTRAPATIENT GENOMHETEROGENICITY OF INDIVIDUAL CIRCULATIVE TUMOR CELLS (CTCS) RELATED TO PHENOTYPIC CTC HETEROGENICITY IN METASTASED, CASTING RESISTANT PROSTATE CANCER (MCRPC)
CN115341033A (zh) 2015-11-03 2022-11-15 艾匹克科学公司 一种表征疾病异质性的方法
WO2017120324A1 (en) 2016-01-06 2017-07-13 Epic Sciences, Inc. Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity

Also Published As

Publication number Publication date
US20190257834A1 (en) 2019-08-22
AU2016203462B2 (en) 2018-07-12
EP3045918A1 (en) 2016-07-20
JP2013508729A (ja) 2013-03-07
JP2018185339A (ja) 2018-11-22
JP2017053860A (ja) 2017-03-16
AU2016203462A1 (en) 2016-06-09
AU2021202220A1 (en) 2021-05-06
EP2491395B1 (en) 2015-09-16
EP2491395A1 (en) 2012-08-29
US20120276555A1 (en) 2012-11-01
JP6352588B2 (ja) 2018-07-04
WO2011050103A1 (en) 2011-04-28
CN107422127A (zh) 2017-12-01
AU2010310688A1 (en) 2012-05-17
EP3385716A2 (en) 2018-10-10
EP3385716A3 (en) 2019-01-09
EP3045918B1 (en) 2017-12-06
CA2778328C (en) 2018-12-18
ES2556639T3 (es) 2016-01-19
AU2018247290A1 (en) 2018-11-01
CA2778328A1 (en) 2011-04-28
US20180100857A1 (en) 2018-04-12
CN102782498A (zh) 2012-11-14
ES2661735T3 (es) 2018-04-03
US20210033612A1 (en) 2021-02-04
US10613089B2 (en) 2020-04-07
EP2491395A4 (en) 2013-05-22

Similar Documents

Publication Publication Date Title
US20230085158A1 (en) Method of using non-rare cells to detect rare cells
US10613089B2 (en) Method of using non-rare cells to detect rare cells
Krebs et al. Circulating tumour cells: their utility in cancer management and predicting outcomes
US20140329917A1 (en) Apparatus, system and method for identifying circulating tumor cells
CN104094116B (zh) 在哺乳动物个体中检测5t4阳性循环肿瘤细胞的方法和诊断5t4阳性癌症的方法
EP1861509B1 (en) A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
US20080113350A1 (en) Blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (FISH)
Sun et al. The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer
Su et al. Biophysical technologies for understanding circulating tumor cell biology and metastasis
Kim et al. Circulating tumor cells: detection methods and potential clinical application in breast cancer
JP2018535432A (ja) 転移性去勢抵抗性前立腺癌（ｍＣＲＰＣ）患者における治療選択のためのバイオマーカーとしてのアンドロゲン受容体バリアント７
JP2012022002A (ja) 循環腫瘍細胞を用いる転移性乳癌患者の療法中の各追跡期間ポイントでの無増悪および全生存を予測する方法
US20250012804A1 (en) Use of microvesicles for benign colorectal polyps and colorectal cancer screening
EP3924733B1 (en) Ccr5-based methods for predicting overall and progression free survival in subjects having cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination